Case Study

Creating A New Dosage Form From An Approved Drug For A New Rare Disease Indication

Source: Pharmaceutics International

By Sundeep Sethia, Senior Director, Pharmaceutical R&D; Veeranna Lolla, RAC, Senior Director, Regulatory Affairs; Shafi Shaik, Principal Scientist, Product Development

science lab clinical trial
access the Case Study!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

Pharmaceutics International